4//SEC Filing
Espinoza Octavio 4
Accession 0002001011-25-000011
CIK 0000886163other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:38 PM ET
Size
13.5 KB
Accession
0002001011-25-000011
Insider Transaction Report
Form 4
Espinoza Octavio
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-14+5,429→ 26,076 total - Tax Payment
Common Stock
2025-02-14$120.00/sh−2,757$330,840→ 23,319 total - Award
Common Stock
2025-02-14+7,390→ 30,709 total - Tax Payment
Common Stock
2025-02-14$120.00/sh−3,803$456,360→ 26,906 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−1,024$122,880→ 25,882 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−782$93,840→ 25,100 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−1,221$146,520→ 23,879 total
Footnotes (3)
- [F1]Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs).
- [F2]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units.
- [F3]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001905248
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:38 PM ET
- Size
- 13.5 KB